Clinical Trials Logo
  1. Home
  2. Permanent Atrial Fibrillation
  3. NCT01765075

Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment — STARLIGHT  

Permanent Atrial Fibrillation Clinical Trial

Official title:
Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment

Clinical Trial Summary

The purpose of the study is to gather electrophysiological data using a multi-electrode mapping catheter during a clinically indicated cardiac ablation procedure for the treatment of persistent atrial fibrillation.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01765075
Study type Observational
Source Boston Scientific Corporation
Contact
Status Completed
Phase N/A
Start date April 2013
Completion date February 2014
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02137187 - Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure Phase 3
Completed NCT02161965 - Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation Phase 4
Not yet recruiting NCT06377046 - Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial N/A
Recruiting NCT05549544 - Clinical Efficacy of Left Bundle Branch Area Pacing for Patients With Permanent Atrial Fibrillation and Heart Failure N/A
Completed NCT00246805 - Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study Phase 4
Completed NCT02695992 - Rate Control in Atrial Fibrillation II Phase 4
Completed NCT02391337 - Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Phase 4